|
|
Volumn 8, Issue 11, 2011, Pages 630-
|
|
Immunotherapy: Seek and destroy: Oncolytic virus shows promise in phase i trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
PEXASTIMOGENE DEVACIREPVEC;
RAS PROTEIN;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG SAFETY;
FLU LIKE SYNDROME;
HUMAN;
METASTASIS POTENTIAL;
NOTE;
ONCOLYTIC VIROTHERAPY;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SOLID TUMOR;
TUMOR IMMUNITY;
VIRUS REPLICATION;
|
|
EID: 85027943105
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc2011143 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
